Poxel Press Release: Adrenoleukodystrophy
Granted Orphan Drug US Designation
Poxel Announces PXL065 and PXL770 Granted Orphan Drug Designation from the U.S. FDA for X-Linked Adrenoleukodystrophy.
To read the full press release: Poxel Press Release

Poxel Announces PXL065 and PXL770 Granted Orphan Drug Designation from the U.S. FDA for X-Linked Adrenoleukodystrophy.
To read the full press release: Poxel Press Release